Longitudinal atherosclerotic changes after radio(chemo)therapy of hypopharyngeal carcinoma.


Journal

Radiation oncology (London, England)
ISSN: 1748-717X
Titre abrégé: Radiat Oncol
Pays: England
ID NLM: 101265111

Informations de publication

Date de publication:
07 May 2020
Historique:
received: 04 10 2019
accepted: 22 04 2020
entrez: 9 5 2020
pubmed: 10 5 2020
medline: 23 3 2021
Statut: epublish

Résumé

Radiotherapy treatment of head and neck cancer affects local arteries and increases the risk of stroke. This study aimed at a closer characterization of this damage and its development in time with a longitudinal study set up. Male patients treated between 2011 and 2016 for hypopharyngeal carcinoma were identified from the in-house clinical data base. They were included into the study if besides the planning CT at least one additional CT image was available from follow-up (13 patients) or at least two MRI scans (16 patients of which 2 were already included). All patients received radiotherapy, and chemotherapy was administered to 16 patients. The time from the beginning of radiotherapy to the last available image ranged from 2 months to 4.5 years. For six segments of the carotid arteries, the number and volume of atherosclerotic plaques were determined from the CT scans, and the intima media thickness from the MRI scans. Information on comorbid cardiovascular disease, hypertension and diabetes mellitus was retrieved from medical records. Total plaque volume rose from 0.25 cm Our study confirmed the thickening of artery walls and the increase in the number of plaques. Results imply that definitive radiation damage to the artery walls can be determined not earlier than about one year after radiotherapy and there is no substantial deterioration thereafter. Reasons for the absence of an observable intima media thickening in patients with diabetes are unclear.

Sections du résumé

BACKGROUND BACKGROUND
Radiotherapy treatment of head and neck cancer affects local arteries and increases the risk of stroke. This study aimed at a closer characterization of this damage and its development in time with a longitudinal study set up.
METHODS METHODS
Male patients treated between 2011 and 2016 for hypopharyngeal carcinoma were identified from the in-house clinical data base. They were included into the study if besides the planning CT at least one additional CT image was available from follow-up (13 patients) or at least two MRI scans (16 patients of which 2 were already included). All patients received radiotherapy, and chemotherapy was administered to 16 patients. The time from the beginning of radiotherapy to the last available image ranged from 2 months to 4.5 years. For six segments of the carotid arteries, the number and volume of atherosclerotic plaques were determined from the CT scans, and the intima media thickness from the MRI scans. Information on comorbid cardiovascular disease, hypertension and diabetes mellitus was retrieved from medical records.
RESULTS RESULTS
Total plaque volume rose from 0.25 cm
CONCLUSION CONCLUSIONS
Our study confirmed the thickening of artery walls and the increase in the number of plaques. Results imply that definitive radiation damage to the artery walls can be determined not earlier than about one year after radiotherapy and there is no substantial deterioration thereafter. Reasons for the absence of an observable intima media thickening in patients with diabetes are unclear.

Identifiants

pubmed: 32381045
doi: 10.1186/s13014-020-01541-3
pii: 10.1186/s13014-020-01541-3
pmc: PMC7206771
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102

Subventions

Organisme : H2020 Euratom
ID : 755523

Références

Am J Surg. 1999 Oct;178(4):323-8
pubmed: 10587192
Interv Neurol. 2014 Aug;2(4):183-92
pubmed: 25337087
Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1197-205
pubmed: 15978738
J Clin Neurol. 2018 Jan;14(1):35-42
pubmed: 29629538
J Clin Ultrasound. 2012 Nov-Dec;40(9):566-71
pubmed: 22811339
Stroke. 2014 Nov;45(11):3257-62
pubmed: 25213342
Eur J Cancer. 2005 May;41(7):1026-30
pubmed: 15862751
Br J Radiol. 2015 Jun;88(1050):20150175
pubmed: 25875781
Radiother Oncol. 2014 Jan;110(1):31-8
pubmed: 24044796
PLoS One. 2014 Dec 31;9(12):e116284
pubmed: 25551559
Br J Radiol. 1998 Aug;71(848):872-5
pubmed: 9828801
Acta Oncol. 2015;54(8):1175-80
pubmed: 25831144
Am J Cardiol. 2016 Sep 1;118(5):771-6
pubmed: 27392510
J Vasc Surg. 2009 Aug;50(2):280-5
pubmed: 19631860
Stroke. 2002 Apr;33(4):977-81
pubmed: 11935047
Laryngoscope. 2000 Nov;110(11):1811-4
pubmed: 11081590
Radiother Oncol. 2016 Feb;118(2):323-9
pubmed: 26705683
PLoS One. 2014 Oct 16;9(10):e110389
pubmed: 25329500
Arch Otolaryngol Head Neck Surg. 1991 Oct;117(10):1135-7
pubmed: 1910699
Oral Oncol. 2004 Oct;40(9):872-8
pubmed: 15380164
Eur Radiol. 2016 Jan;26(1):72-8
pubmed: 26408306
Radiat Oncol. 2013 Nov 07;8:261
pubmed: 24196030
J Vasc Surg. 2004 Feb;39(2):409-15
pubmed: 14743145
Stroke. 2011 Sep;42(9):2410-8
pubmed: 21817150

Auteurs

Cristoforo Simonetto (C)

Helmholtz Zentrum München GmbH, Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), German Research Center for Environmental Health, Institute of Radiation Medicine, Ingolstädter Landstraße 1, D-85764, Neuherberg, Germany. cristoforo.simonetto@helmholtz-muenchen.de.

Michael Mayinger (M)

Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany.
Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Thamer Ahmed (T)

Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany.

Kai Borm (K)

Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany.

Pavel Kundrát (P)

Helmholtz Zentrum München GmbH, Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), German Research Center for Environmental Health, Institute of Radiation Medicine, Ingolstädter Landstraße 1, D-85764, Neuherberg, Germany.

Steffi Pigorsch (S)

Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany.
Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partnerstandort München, Munich, Germany.

Jan Christian Kaiser (JC)

Helmholtz Zentrum München GmbH, Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), German Research Center for Environmental Health, Institute of Radiation Medicine, Ingolstädter Landstraße 1, D-85764, Neuherberg, Germany.

Stephanie E Combs (SE)

Helmholtz Zentrum München GmbH, Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), German Research Center for Environmental Health, Institute of Radiation Medicine, Ingolstädter Landstraße 1, D-85764, Neuherberg, Germany.
Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany.
Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partnerstandort München, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH